Vertex Pharmaceuticals (Ondo Tokenized) VRTXON
Rank #12361$436.53
-0.35%
CoinGecko · just now
24h
-0.35%
7d
-1.35%
30d
-4.46%
1y
+0.00%
Vertex Pharmaceuticals (Ondo Tokenized) Statistics
- Market Cap
- $451
- 24h Volume
- $57,002
- 24h High
- $441.79
- 24h Low
- $436.04
- Circulating Supply
- 1.034 VRTXON
- Max Supply
- Unlimited
- All-Time High
- $462.50
- All-Time Low
- $426.89
About Vertex Pharmaceuticals (Ondo Tokenized)
VRTXon is the Ondo Tokenized version of Vertex Pharmaceuticals, giving tokenholders economic exposure similar to holding VRTX and reinvesting any dividends. Ondo tokenized stocks enable non-US retail and institutional users around the world to instantly mint and redeem tokenized U.S. stocks and ETFs, 24 hours a day, five days a week with full access to traditional exchange liquidity. Additional restrictions apply. Learn more at ondo.finance/global-markets.
Frequently Asked Questions about Vertex Pharmaceuticals (Ondo Tokenized)
What is Vertex Pharmaceuticals (Ondo Tokenized) (VRTXON)?
Vertex Pharmaceuticals (Ondo Tokenized) (VRTXON) is a cryptocurrency that can be traded on various exchanges. It has a current market capitalization of $451, making it one of the notable digital assets in the crypto market.
What is the current price of Vertex Pharmaceuticals (Ondo Tokenized)?
The current price of Vertex Pharmaceuticals (Ondo Tokenized) (VRTXON) is $436.53. Prices update in real-time based on market activity across major cryptocurrency exchanges.
Where can I buy Vertex Pharmaceuticals (Ondo Tokenized)?
You can buy Vertex Pharmaceuticals (Ondo Tokenized) (VRTXON) on major cryptocurrency exchanges such as Binance, Coinbase, and Kraken. Always use a reputable exchange and enable two-factor authentication to secure your account.
Is Vertex Pharmaceuticals (Ondo Tokenized) a good investment?
Whether Vertex Pharmaceuticals (Ondo Tokenized) is a good investment depends on your financial goals, risk tolerance, and research. Cryptocurrency markets are highly volatile. Always do your own research and consider consulting a financial advisor before investing.
